Margarita Pavez

2.2k total citations
42 papers, 1.7k citations indexed

About

Margarita Pavez is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Margarita Pavez has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Public Health, Environmental and Occupational Health, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Obstetrics and Gynecology. Recurrent topics in Margarita Pavez's work include Reproductive Health and Contraception (31 papers), Maternal and fetal healthcare (9 papers) and Maternal and Perinatal Health Interventions (7 papers). Margarita Pavez is often cited by papers focused on Reproductive Health and Contraception (31 papers), Maternal and fetal healthcare (9 papers) and Maternal and Perinatal Health Interventions (7 papers). Margarita Pavez collaborates with scholars based in United States, Brazil and Finland. Margarita Pavez's co-authors include Soledad Dı́az, H.B. Croxatto, Irving Sivin, Vivian Brache, Janet Stern, Francisco Alvarez, Aníbal Faúndes, Daniel R. Mishell, Horacio B. Croxatto and Juan Dı́az and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Human Reproduction and European Journal of Endocrinology.

In The Last Decade

Margarita Pavez

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margarita Pavez United States 24 1.4k 585 451 447 158 42 1.7k
Francisco Alvarez United States 23 1.1k 0.8× 513 0.9× 360 0.8× 300 0.7× 175 1.1× 39 1.5k
John K. Jain United States 23 1.2k 0.9× 517 0.9× 709 1.6× 576 1.3× 89 0.6× 48 1.7k
Leila Cochón United States 19 853 0.6× 406 0.7× 299 0.7× 248 0.6× 128 0.8× 37 1.1k
Maria Lacarra United States 22 653 0.5× 348 0.6× 135 0.3× 206 0.5× 100 0.6× 31 987
P.F.A. Van Look Switzerland 23 821 0.6× 591 1.0× 408 0.9× 221 0.5× 140 0.9× 55 1.6k
A.M. Salvatierra Chile 20 766 0.6× 452 0.8× 250 0.6× 196 0.4× 85 0.5× 32 1.1k
Michael A. Thomas United States 20 626 0.5× 507 0.9× 342 0.8× 207 0.5× 84 0.5× 74 1.2k
Ilza Monteiro Brazil 22 803 0.6× 394 0.7× 392 0.9× 519 1.2× 149 0.9× 64 1.2k
Carole Gilling‐Smith United Kingdom 25 1.6k 1.1× 2.0k 3.5× 285 0.6× 102 0.2× 398 2.5× 48 2.9k
Daniel R. Mishell United States 11 428 0.3× 88 0.2× 174 0.4× 208 0.5× 63 0.4× 14 679

Countries citing papers authored by Margarita Pavez

Since Specialization
Citations

This map shows the geographic impact of Margarita Pavez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margarita Pavez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margarita Pavez more than expected).

Fields of papers citing papers by Margarita Pavez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margarita Pavez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margarita Pavez. The network helps show where Margarita Pavez may publish in the future.

Co-authorship network of co-authors of Margarita Pavez

This figure shows the co-authorship network connecting the top 25 collaborators of Margarita Pavez. A scholar is included among the top collaborators of Margarita Pavez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margarita Pavez. Margarita Pavez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brache, Vivian, Francisco Alvarez, M.L. Forcelledo, et al.. (2005). Feasibility study of Nestorone®–ethinylestradiol vaginal contraceptive ring for emergency contraception. Contraception. 73(1). 46–52. 16 indexed citations
2.
Pavez, Margarita, et al.. (2004). Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant® implant users. Contraception. 70(1). 47–54. 26 indexed citations
3.
Sivin, Irving, Livia Wan, Sirpa Ranta, et al.. (2001). Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants☆. Contraception. 64(1). 43–49. 62 indexed citations
4.
Sivin, Irving, Daniel R. Mishell, Soledad Dı́az, et al.. (2000). Prolonged effectiveness of Norplant® capsule implants: a 7-year study. Contraception. 61(3). 187–194. 38 indexed citations
5.
Sivin, Irving, Sirpa Ranta, Philip D. Darney, et al.. (1997). Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants. Contraception. 55(2). 81–85. 52 indexed citations
6.
Sivin, Irving, O. A. C. Viegas, I Campodónico, et al.. (1997). "Clinical Performance of a New Two-rod Levonorgestrel Contraceptive Implant: A Three-year Randomized Study with Norplant Implants as Controls". Studies in Family Planning. 28(3). 266–266. 1 indexed citations
7.
Lähteenmäki, Pekka, Daniel R. Mishell, Soledad Dı́az, et al.. (1997). First week drug concentrations in women with levonorgestrel rod or Norplant® capsule implants. Contraception. 56(5). 317–321. 28 indexed citations
8.
Noé, Gabriela, Margarita Pavez, & H. B. Croxatto. (1992). Changes in serum levels of SHBG, endogenous ligands and levonorgestrel induced by ethinylestradiol in NORPLANTR users. Contraception. 45(3). 187–201. 8 indexed citations
9.
Sivin, Irving, Jeffrey Stern, Soledad Dı́az, et al.. (1992). Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. American Journal of Obstetrics and Gynecology. 166(4). 1208–1213. 67 indexed citations
10.
Dı́az, Soledad, Margarita Pavez, Alfred Moo-Young, C. Wayne Bardin, & H.B. Croxatto. (1991). Clinical trial with 3-keto-desogestrel subdermal implants. Contraception. 44(4). 393–408. 62 indexed citations
11.
Sivin, Irving, Janet Stern, Elsimar Metzker Coutinho, et al.. (1991). Prolonged intrauterine contraception: A seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. Contraception. 44(5). 473–480. 172 indexed citations
12.
Sivin, Irving, Mamdouh M. Shaaban, Viveca Odlind, et al.. (1990). A randomized trial of the Gyne T∗ 380 and Gyne T∗ 380 slimline intrauterine copper devices. Contraception. 42(4). 379–389. 16 indexed citations
13.
Sivin, Irving, Daniel R. Mishell, Donna Shoupe, et al.. (1990). Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the Copper T 380Ag intrauterine devices: A five-year randomized study. Contraception. 42(4). 361–378. 148 indexed citations
14.
Croxatto, H.B., Soledad Dı́az, Margarita Pavez, et al.. (1988). Clearance of levonorgestrel from the circulation following removal of NORPLANTR subdermal implants. Contraception. 38(5). 509–523. 24 indexed citations
15.
Dı́az, Soledad, Margarita Pavez, Patricia Y. Miranda, Eva Johansson, & H.B. Croxatto. (1987). Long-term follow-up of women treated with NORPLANTR implants. Contraception. 35(6). 551–567. 36 indexed citations
16.
Dı́az, Soledad, Margarita Pavez, Horacio Cárdenas, & H. B. Croxatto. (1987). Recovery of fertility and outcome of planned pregnancies after the removal of NORPLANTR subdermal implants or Copper-T IUDs. Contraception. 35(6). 569–579. 26 indexed citations
17.
Pavez, Margarita, et al.. (1987). "Bleeding pattern, outcome of accidental pregnancies and levonorgestrel plasma levels associated with method failure in Norplant implants users". Studies in Family Planning. 18(3). 177–177. 4 indexed citations
18.
Sivin, Irving, Janet Stern, Juan Dı́az, et al.. (1987). Two years of intrauterine contraception with levonorgestrel and with copper: A randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day device. Contraception. 35(3). 245–255. 60 indexed citations
19.
Dı́az, Soledad, Margarita Pavez, C. Herreros, Eva Johansson, & H.B. Croxatto. (1986). Bleeding pattern, outcome of accidental pregnancies and levonorgestrel plasma levels associated with method failure in NORPLANTR implants users. Contraception. 33(4). 347–356. 16 indexed citations
20.
Croxatto, H.B., Soledad Dı́az, Dale N. Robertson, & Margarita Pavez. (1983). Clinical chemistry in women treated with levonorgestrel implants (NORPLANT™∗∗NORPLANT™is the Population Council's trademark for subdermal implants containing levonorgestrel.) or a TCu 200 IUD. Contraception. 27(3). 281–288. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Alvarez Breakdown of academic impact, for papers by John K. Jain Breakdown of academic impact, for papers by Leila Cochón Breakdown of academic impact, for papers by Maria Lacarra Breakdown of academic impact, for papers by P.F.A. Van Look Breakdown of academic impact, for papers by A.M. Salvatierra Breakdown of academic impact, for papers by Michael A. Thomas Breakdown of academic impact, for papers by Ilza Monteiro Breakdown of academic impact, for papers by Carole Gilling‐Smith Breakdown of academic impact, for papers by Daniel R. Mishell
Rankless by CCL
2026